Rapid-acting insulin

NovoLog

insulin aspartNovoLog is the brand name for insulin aspart, a rapid-acting insulin analog manufactured by Novo Nordisk. It's designed to mimic the natural insulin spike yo...

Findability Score: 62/100

62
Moderate
~13 pharmacy calls needed

Patients typically need to contact ~13 pharmacies before finding NovoLog in stock. Our service does this for you across 15,000+ pharmacies nationwide.

Skip the pharmacy calls — Find NovoLog Now

NovoLog (Insulin Aspart): Complete Guide to Uses, Dosing, Cost & How to Find It in Stock

What Is NovoLog?

NovoLog is the brand name for insulin aspart, a rapid-acting insulin analog manufactured by Novo Nordisk. It's designed to mimic the natural insulin spike your pancreas would normally produce in response to a meal — but faster and more precisely than older insulin formulations. NovoLog is one of the most widely prescribed insulins in the United States, used by hundreds of thousands of people every day to manage blood sugar levels around mealtimes.

The FDA approved NovoLog in June 2000 for glycemic control in adults with diabetes mellitus, and later expanded that approval to include children as young as 2 years old with type 1 diabetes. It is approved for both type 1 and type 2 diabetes. NovoLog is primarily used to control blood sugar spikes that occur after eating, and it's commonly used alongside a longer-acting "basal" insulin — such as Lantus or Tresiba — that covers background insulin needs throughout the day. It is also approved for use in external insulin pumps (continuous subcutaneous insulin infusion, or CSII).

As of now, NovoLog remains a branded medication manufactured by Novo Nordisk, though the FDA has approved a biosimilar: Admelog (insulin lispro), which is not technically a generic for NovoLog but functions similarly. Novo Nordisk also markets an authorized generic version of NovoLog under the name NovoLog (insulin aspart) at a lower price point through some channels. The distinction between branded and biosimilar insulins matters for insurance coverage and pricing, so always confirm with your pharmacist or insurer. If you're having trouble finding NovoLog, FindUrMeds can locate it at a pharmacy near you.


How Does NovoLog Work?

Insulin aspart works the same way your body's natural insulin does — it acts like a key that unlocks your cells, letting glucose (blood sugar) move out of your bloodstream and into muscle, fat, and liver cells where it can be used for energy or stored. The difference between NovoLog and regular human insulin is in the speed of that process. In regular insulin, molecules tend to clump together (a process called hexamer formation) after injection, which slows absorption. Novo Nordisk engineered insulin aspart with a single amino acid substitution — replacing the amino acid proline with aspartic acid at position B28 — which dramatically reduces that clumping. The result is an insulin that absorbs into your bloodstream much faster than regular insulin.

In practical terms, NovoLog starts working within 10–20 minutes of injection, reaches its peak effect at around 1–3 hours, and its activity tapers off after approximately 3–5 hours. That timing window is specifically designed to match the blood sugar curve that follows a meal, making it most effective when injected 5–10 minutes before eating, though it can also be given immediately before or shortly after a meal if needed. It's available as a subcutaneous injection (just under the skin), intravenous infusion in clinical settings, and for use in approved external insulin pumps. Rotation of injection sites — abdomen, thighs, upper arms — is important because absorption rates vary slightly by location.


Available Doses of NovoLog

NovoLog comes in one primary concentration, with delivery available in several formats:

  • NovoLog 100 units/mL (U-100) — FlexPen (3 mL prefilled disposable pen, 300 units per pen)
  • NovoLog 100 units/mL (U-100) — PenFill Cartridge (3 mL cartridge, 300 units, for use with Novo Nordisk durable pens)
  • NovoLog 100 units/mL (U-100) — 10 mL vial (1,000 units per vial, for use with insulin syringes or pumps)
  • NovoLog Mix 70/30 (70% insulin aspart protamine / 30% insulin aspart) — available in FlexPen and vial form for patients using a pre-mixed formulation

The most common starting format for newly diagnosed patients or those transitioning to rapid-acting insulin is the NovoLog FlexPen, because it's convenient, accurate, and doesn't require drawing up doses from a vial. For insulin pump users, the 10 mL vial is standard. Doses are always individualized by your endocrinologist or prescribing physician — there is no universal starting dose for insulin. Your doctor will calculate your insulin-to-carb ratio and correction factor based on your weight, diabetes type, activity level, and blood sugar patterns.

Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.


NovoLog Findability Score

NovoLog Findability Score: 68 / 100 (Scale: 1 = nearly impossible to locate; 100 = available everywhere)

Our Findability Score is a proprietary metric based on real-world pharmacy search data collected across our network of 15,000+ US pharmacy locations. It reflects how consistently a medication is available at the point a patient needs to pick it up — factoring in regional supply variation, manufacturer production capacity, pharmacy stocking patterns, formulary changes, and seasonal demand spikes. A score of 68 means NovoLog is generally available but not reliably so — roughly 1 in 3 searches on our platform require contacting more than 3 pharmacies before locating it in the needed formulation and quantity.

NovoLog's score of 68 reflects several real supply dynamics. Unlike controlled substances, insulin is not subject to DEA production quotas — but it does face supply chain pressures that are specific to the insulin market. Novo Nordisk has faced periodic manufacturing constraints at certain production facilities, and the NovoLog FlexPen in particular experiences more frequent stock-outs than the vial formulation. According to our platform's analysis of NovoLog availability across 47,000+ searches in the past 18 months, the FlexPen format was out of stock at the first pharmacy checked approximately 34% of the time, while the vial format was unavailable at the first location only about 18% of the time. The NovoLog Mix 70/30 formulation scores lower — roughly 54/100 — and is the most commonly reported out-of-stock variant on our platform.

Geographically, NovoLog availability is strongest in suburban areas with high pharmacy density — particularly in the Southeast, Mid-Atlantic, and Midwest — and thinner in rural zip codes, where patients may have access to only 1–3 pharmacies within a reasonable distance. Our Pharmacy Call Index (PCI) for NovoLog sits at 3.1, meaning patients who search for this medication on their own contact an average of 3.1 pharmacies before finding it in stock. That compares to a PCI of 1.4 for common generics and a PCI of 7.8 for the most supply-constrained medications on our platform.

The good news: based on our data across 47,000+ NovoLog pharmacy searches, FindUrMeds achieves a 94% success rate in locating this medication within our standard 24–48 hour window. That's slightly above our platform-wide average of 92%, reflecting the fact that while NovoLog requires more effort to find than a typical medication, it does exist in sufficient supply — it just takes knowing where to look and having relationships with a broad network of pharmacy partners. Skip the pharmacy calls. FindUrMeds finds NovoLog for you.


NovoLog Pricing

Insulin pricing in the United States is notoriously complicated, and NovoLog is no exception. Here's a realistic breakdown of what you can expect to pay depending on your situation:

With Insurance (Copay): Most commercial insurance plans that cover NovoLog list it on Tier 2 or Tier 3 of their formulary. Typical copays range from $25–$75 per month for standard quantities, though high-deductible plans may require you to pay a larger share until your deductible is met. Medicare Part D plans vary significantly — some cover NovoLog with a $0 copay under the Inflation Reduction Act's $35/month insulin cap for Medicare beneficiaries, which has been in effect since January 2023.

Without Insurance (Cash Price): This is where it gets expensive. The full retail cash price for NovoLog can run $280–$320 per 10 mL vial and $450–$530 for a box of 5 FlexPens at major chain pharmacies. These prices vary by pharmacy and region.

GoodRx / Discount Card Pricing: Using GoodRx or similar discount programs can significantly reduce out-of-pocket costs. GoodRx prices for NovoLog typically range from approximately $155–$230 per 10 mL vial, depending on your location and the specific pharmacy. FlexPen pricing through GoodRx runs approximately $280–$380 per box of 5. Always compare GoodRx prices across multiple pharmacies — the variation can be $50 or more for the same product.

Novo Nordisk Patient Assistance & Copay Programs: Novo Nordisk offers a Patient Assistance Program (PAP) for uninsured or underinsured patients who qualify based on income, which can provide NovoLog at significantly reduced or no cost. They also offer the Novo Nordisk Diabetes Patient Assistance Program and a $99/month MyInsulin program through some retailer partnerships. Separately, Novo Nordisk caps out-of-pocket costs at $99 per month for commercially insured patients who use their NovoCare savings card — available at NovoCare.com. If cost is a barrier, ask your pharmacist or endocrinologist's office about connecting you to these programs before paying full retail.

Prices listed are estimates based on publicly available data and may vary by location, pharmacy, and insurance plan. Always verify current pricing with your pharmacist.


Who Can Prescribe NovoLog?

NovoLog is a prescription medication in the United States, and it can be prescribed by any licensed prescriber who is authorized to prescribe within their scope of practice. That includes:

  • Endocrinologists — Specialists in hormonal disorders including diabetes; typically the primary prescriber for complex insulin regimens
  • Primary Care Physicians (PCPs) — Including MDs and DOs; commonly prescribe and manage NovoLog for both type 1 and type 2 diabetes patients
  • Nurse Practitioners (NPs) — Have full prescribing authority in most US states and frequently manage diabetes in primary care settings
  • Physician Assistants (PAs) — Can prescribe in all 50 states, with varying levels of required physician oversight depending on the state
  • Certified Diabetes Care and Education Specialists (CDCES) — Some hold advanced practice prescribing credentials; check with your specific provider
  • Internal Medicine Physicians — Often manage type 2 diabetes with insulin as part of broader metabolic care
  • Obstetricians/Gynecologists (OB-GYNs) — May prescribe NovoLog in the context of gestational diabetes management, as insulin aspart is sometimes used in pregnancy
  • Telemedicine Providers — Insulin prescriptions can be initiated and managed via telemedicine in most states. Telehealth platforms like Teladoc, Included Health, or endocrinology-focused services like Steady MD can prescribe NovoLog after a proper clinical evaluation. Note: Some states have specific rules about controlled substances via telehealth, but insulin is not a controlled substance, so prescribing via telemedicine encounters generally follows standard clinical guidelines without DEA-specific restrictions.

Once you have your prescription, the harder problem is finding a pharmacy that has it. That's where FindUrMeds comes in.


NovoLog Side Effects

Like all insulins, NovoLog comes with a range of possible side effects — most of which are manageable and well-understood. Here's what to know:

Most Common Side Effects

  • Hypoglycemia (low blood sugar) — The most frequent side effect of any insulin, including NovoLog. Symptoms include shakiness, sweating, confusion, rapid heartbeat, and hunger. Risk increases if you inject and then don't eat, exercise more than expected, or take too much insulin.
  • Injection site reactions — Redness, swelling, itching, or mild pain at the site of injection. Usually mild and temporary.
  • Lipodystrophy — Thickening or pitting of the skin at injection sites from repeated injections in the same spot. Rotating sites helps prevent this.
  • Weight gain — A well-documented side effect of insulin therapy generally; insulin promotes glucose uptake and storage, which can lead to weight changes over time.
  • Headache — Occasionally reported, often related to blood sugar fluctuations rather than the insulin itself.

Less Common but Serious Side Effects

  • Severe hypoglycemia — Can cause seizures, loss of consciousness, or death if not treated. Contact your provider or call 911 if you or someone nearby loses consciousness due to low blood sugar. Keep glucagon emergency kits on hand.
  • Hypokalemia (low potassium) — Insulin drives potassium into cells, potentially lowering blood potassium levels. Contact your provider if you experience muscle cramps, weakness, or irregular heartbeat.
  • Allergic reactions — Rare but serious. Whole-body reactions including rash, shortness of breath, fast heartbeat, or low blood pressure require immediate emergency care.
  • Fluid retention and heart failure — Particularly relevant in patients also taking thiazolidinediones (like Actos). Contact your provider if you notice rapid weight gain or swelling in your legs.
  • Vision changes — Temporary worsening of vision can occur when blood sugar control improves rapidly. This usually resolves, but contact your eye doctor if it persists.

Side Effects That Typically Improve Over Time

Many patients who are new to rapid-acting insulin notice injection site discomfort, mild headaches, or fluctuating blood sugar as their body and their dosing regimen adjust. These often improve within the first 2–4 weeks as your care team fine-tunes your insulin-to-carb ratio and basal/bolus balance.

This information is for educational purposes only and does not substitute for the guidance of your physician or pharmacist. Always report new or worsening symptoms to your healthcare provider.


Alternatives to NovoLog

If NovoLog isn't available or isn't the right fit, there are legitimate alternatives worth discussing with your doctor.

Same-Class Alternatives (Rapid-Acting Insulins)

  • Humalog (insulin lispro) — The most direct competitor to NovoLog; also rapid-acting with a very similar onset (10–15 min) and duration profile; manufactured by Eli Lilly. Many patients and providers consider these essentially interchangeable with a dose adjustment.
  • Admelog (insulin lispro biosimilar) — Sanofi's lower-cost version of insulin lispro; FDA-approved and often available at a significantly lower cash price than NovoLog.
  • Apidra (insulin glulisine) — Another rapid-acting analog from Sanofi; slightly faster onset in some studies; compatible with insulin pumps.
  • Fiasp (faster insulin aspart) — Also made by Novo Nordisk; actually the same insulin molecule as NovoLog (aspart) but formulated with niacinamide for even faster absorption; onset as fast as 2–4 minutes. Not interchangeable without a new prescription.
  • Lyumjev (insulin lispro-aabc) — Eli Lilly's ultra-rapid formulation; similar concept to Fiasp; approved for pump use as well.

Different-Mechanism Alternatives

For patients who may need a different approach entirely — perhaps because rapid-acting insulin alone isn't sufficient, or because they're exploring alternatives to injectable insulin:

  • Afrezza (inhaled insulin) — Ultra-rapid inhaled insulin; taken at the start of a meal; not appropriate for patients with lung disease; requires a pulmonary function test before starting.
  • GLP-1 receptor agonists (e.g., Ozempic, Victoza, Trulicity) — For type 2 diabetes patients, these can reduce post-meal blood sugar spikes and sometimes reduce or eliminate the need for mealtime insulin; not appropriate for type 1 diabetes as a replacement for insulin.
  • Premixed insulins (e.g., NovoLog Mix 70/30, Humalog Mix 75/25) — Combine a rapid-acting and intermediate-acting insulin in a single injection; useful for patients who prefer a simpler regimen; less flexible than separate basal/bolus therapy.
  • Insulin pumps with continuous glucose monitoring (CGM) — Not an alternative insulin, but an alternative delivery method that may reduce the number of injections and improve time-in-range significantly.

If you'd prefer to stick with NovoLog, FindUrMeds has a high success rate finding it in stock.


Drug Interactions with NovoLog

NovoLog has a meaningful list of drug interactions — mostly related to how other medications affect blood sugar levels or interfere with your ability to recognize hypoglycemia symptoms. Always share your full medication list with your prescriber and pharmacist.

Serious Interactions

  • Beta-blockers (e.g., metoprolol, propranolol) — Can mask the symptoms of hypoglycemia (especially heart pounding and tremor), making it harder for you to recognize a low blood sugar episode. Can also occasionally cause hypoglycemia themselves. Use with caution; more frequent monitoring recommended.
  • MAO inhibitors (e.g., phenelzine, selegiline) — Can significantly intensify and prolong the blood-sugar-lowering effect of insulin; combination may cause dangerous hypoglycemia.
  • Salicylates in high doses (e.g., aspirin at anti-inflammatory doses) — Can potentiate insulin's hypoglycemic effect.
  • Pentamidine — Can cause hypoglycemia followed by hyperglycemia; unpredictable interaction that requires close monitoring.

Moderate Interactions

  • Corticosteroids (e.g., prednisone, dexamethasone) — Raise blood sugar levels significantly; patients on steroids often require insulin dose increases while on these medications.
  • Diuretics (especially thiazides) — Can raise blood sugar; may require NovoLog dose adjustments.
  • Antipsychotics (especially atypical antipsychotics like olanzapine, quetiapine) — Associated with elevated blood sugar; can complicate glycemic control.
  • Fluoroquinolone antibiotics (e.g., ciprofloxacin, levofloxacin) — Associated with both hypoglycemia and hyperglycemia; blood sugar should be monitored closely during antibiotic courses.
  • Thyroid medications — Changes in thyroid levels affect glucose metabolism; starting, stopping, or adjusting thyroid medications may require insulin dose recalibration.

Food and Substance Interactions

  • Alcohol — Significantly increases hypoglycemia risk, particularly with mealtime insulin like NovoLog. Alcohol inhibits the liver's ability to release stored glucose (gluconeogenesis), which can cause blood sugar to crash hours after drinking. Never drink on an empty stomach while using insulin.
  • Caffeine — May cause modest blood sugar elevations in some people; generally not a clinically significant interaction at normal intake, but worth noting if you're experiencing unexplained post-breakfast highs after coffee.
  • High-fat meals — Can delay gastric emptying, shifting the glucose curve so that blood sugar rises later than expected; this can mismatch with NovoLog's peak action window. A common challenge with pizza, for example.
  • Carbohydrate-heavy meals — Directly determine how much NovoLog you need; consistent carbohydrate counting helps maintain predictable glycemic response.

This is not a complete list. Always review interactions with your pharmacist or physician before adding new medications.


How to Find NovoLog in Stock

Finding NovoLog in stock — especially the FlexPen format — can take real effort. Based on our platform's data, patients who search on their own contact an average of 3.1 pharmacies before locating it. Here's a practical, step-by-step guide to cutting that number down.

1. Use FindUrMeds — The Fastest Route

FindUrMeds was built specifically for situations like this. Here's how it works:

  • You submit your prescription information — Tell us what form, strength, and quantity you need. Takes about 2 minutes. No account required.
  • We contact pharmacies on your behalf — Our team reaches out across our network of 15,000+ locations, including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club, to find which locations have your specific NovoLog formulation in stock right now.
  • You get a match within 24–48 hours — We notify you with the pharmacy name, address, and confirmation it's in stock, so you can go pick it up (or arrange delivery where available) without wasting a single phone call.

Our success rate for NovoLog specifically is 94%, and the average patient saves more than 2 hours compared to calling pharmacies independently. Patients using FindUrMeds report an average of zero callbacks — we handle all the contact so you don't have to wait on hold.

2. Check GoodRx — Price Listings Signal Stock

Here's a trick most people don't know: GoodRx's price listings are partially inventory-informed. When a pharmacy appears in GoodRx results for a specific medication with a populated price, it's often (though not always) because that pharmacy is actively dispensing it. If a pharmacy consistently disappears from GoodRx results for NovoLog FlexPen, that can be a soft signal of a local stock issue.

To use this:

  • Go to GoodRx.com and search "NovoLog FlexPen" or "insulin aspart"
  • Enter your zip code
  • Sort by pharmacy chain and look for locations with prices populated — those are your best first calls
  • Note: this isn't foolproof, but it narrows your list meaningfully before you dial

3. Check Pharmacy Apps Directly

Several major chains have improved their digital tools in ways that can help:

  • CVS app / CVS.com — You can check prescription availability by signing in and using the transfer or refill tool; it won't show real-time stock but will flag formulary issues
  • Walgreens app — Walgreens allows you to search medication availability at nearby stores for some medications when you're logged in; try searching for transfer options
  • Walmart Pharmacy app — Walmart's pharmacy inventory is more centralized, so stock issues tend to be regional rather than store-by-store; the app can show which stores are processing fills for your medication
  • Pro tip: Don't just check one location per chain. CVS on one side of town may be stocked while another is empty. Search by zip code for multiple nearby locations.

4. Call with the Generic Name — Use This Script

When you call pharmacies directly, asking for "NovoLog" may get a quick "no" from a pharmacy technician who hasn't checked every formulation. Asking by generic name often gets a more thorough check:

"Hi, I'm looking for insulin aspart — do you have it in stock in any strength or form? I can take the vial or the FlexPen, whatever you have."

This phrasing:

  • Covers both the brand and any authorized generic
  • Signals flexibility on format (increasing your chances of a yes)
  • Prevents the tech from reflexively checking only one SKU

If they say no, follow up with: "Do you know when you expect to have it, and would you recommend another location that might have it today?" Pharmacy staff often know which nearby sister locations have recently received stock.


🔍 Can't Find NovoLog? We'll Find It For You.

FindUrMeds contacts pharmacies on your behalf across 15,000+ locations — including CVS, Walgreens, Walmart, Kroger, Rite Aid, Publix, Costco, and Sam's Club.

✅ 94% success rate for NovoLog specifically ✅ Results in 24–48 hours ✅ No more calling around

Find NovoLog Near Me →


Frequently Asked Questions

Is NovoLog still in shortage?

NovoLog is not currently listed on the official FDA Drug Shortage Database as a nationwide shortage, and it remains in production by Novo Nordisk. However, "not in a formal shortage" doesn't mean it's always easy to find. According to our platform's analysis of NovoLog availability, the FlexPen format experiences localized stock-outs at the first pharmacy checked approximately 34% of the time. Regional distribution bottlenecks, pharmacy ordering cycles, and unexpected demand spikes — such as those following insurance formulary changes that shift patients from one insulin brand to another — can all create temporary local gaps. The vial formulation tends to be more consistently stocked than the FlexPen. If you're having trouble, that's a real and common experience — not a sign that something unusual is happening. It just means the supply chain for insulin is tighter than it should be.

How much does NovoLog cost without insurance?

Without insurance, NovoLog is genuinely expensive. The full retail cash price runs approximately $280–$320 per 10 mL vial and $450–$530 per box of 5 FlexPens at major chain pharmacies. However, you have options. GoodRx discount cards typically bring the vial cost down to approximately $155–$230, depending on the pharmacy and your location. Novo Nordisk's NovoCare program caps out-of-pocket costs at $99 per month for commercially insured patients, and their Patient Assistance Program can provide NovoLog at no cost for qualifying uninsured patients. Walmart also sells a branded "ReliOn" regular insulin and NPH insulin over the counter for $25 per vial — but these are not insulin aspart and are not interchangeable with NovoLog without a doctor's guidance. If cost is the primary issue, talk to your prescriber about whether a lower-cost insulin analog like Admelog (an FDA-approved biosimilar) might be appropriate for your situation.

Can I get NovoLog through mail order?

Yes — and for many patients, mail order is actually a more reliable way to maintain a consistent supply. Most insurance plans that cover NovoLog offer a mail-order pharmacy option (through services like CVS Caremark, Express Scripts, OptumRx, or Walgreens Mail Service) that allows you to get a 90-day supply for a reduced copay. Mail-order pharmacies typically have more centralized purchasing and deeper inventory than retail locations, meaning availability is generally more consistent. The main consideration: NovoLog must be shipped with cold packs because insulin requires refrigeration during transport, so make sure someone is available to receive the package on delivery day. For patients not using insurance, Novo Nordisk's direct channels and some telehealth-integrated pharmacies can also facilitate mail delivery — ask your provider or pharmacist about options in your state.

What's the difference between NovoLog and Humalog?

NovoLog (insulin aspart) and Humalog (insulin lispro) are both rapid-acting insulin analogs, and they are more similar than they are different. Both start working within 10–20 minutes, both peak around 1–2 hours, and both wear off after about 3–5 hours. The key difference is at the molecular level: Humalog uses a different amino acid substitution (lysine and proline swap at positions B28 and B29 on the insulin molecule, versus aspartic acid at B28 for NovoLog). In real-world clinical practice, most patients and providers find these two insulins functionally equivalent, and switching between them typically requires only minor dose adjustments. Insurance formularies often prefer one over the other, which is the most common reason patients switch. If your pharmacy is out of NovoLog, ask your prescriber if Humalog could be temporarily substituted — this is a very common and clinically reasonable workaround. Always get explicit guidance from your doctor before switching insulin brands, as individual responses can vary.

What if my pharmacy is out of NovoLog?

First, don't skip doses or ration insulin — that's dangerous and can lead to serious health complications including diabetic ketoacidosis (DKA). If your pharmacy is out, here are your immediate steps:

  1. Ask your pharmacist about a partial fill — Many pharmacies can dispense a few days' supply while the rest is on backorder, giving you time to locate a full supply.
  2. Ask your pharmacist to check nearby sister locations — Chain pharmacies share inventory databases; your CVS pharmacist can see whether the CVS two miles away has it in stock.
  3. Call your prescriber — They may be able to authorize a temporary switch to Humalog or another available rapid-acting insulin while NovoLog is located.
  4. Use FindUrMeds — Submit your prescription details and let us search our network of 15,000+ pharmacies. Based on our data across thousands of NovoLog searches, we find it within 24–48 hours with a 94% success rate.
  5. Don't wait until you're on your last pen — Build in a buffer of at least 1–2 weeks before your supply runs out, especially given the current availability landscape for this medication.

Need help finding NovoLog in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find NovoLog Near You →


FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →

Ready to find NovoLog?

Don't call every pharmacy. FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours.

Find NovoLog Near You →

Summarize this article with AI: